NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Treatment of severe motion sickness with antimotion sickness drug injectionsThis report concerns the use of intramuscular injections of scopolamine, promethazine, and dramamine to treat severely motion sick individuals participating in parabolic flight experiments. The findings indicate that a majority of individuals received benefit from 50-mg injections of promethazine or 0.5 mg-injections of scopolamine. By contrast, 50-mg injections of dramamine and 25-mg injections of promethazine were nonbeneficial. The use of antimotion drug injections for treating space motion sickness is discussed.
Document ID
19870063043
Acquisition Source
Legacy CDMS
Document Type
Reprint (Version printed in journal)
Authors
Graybiel, Ashton
(Brandeis Univ. Waltham, MA, United States)
Lackner, James R.
(Brandeis University Waltham, MA, United States)
Date Acquired
August 13, 2013
Publication Date
August 1, 1987
Publication Information
Publication: Aviation, Space, and Environmental Medicine
Volume: 58
ISSN: 0095-6562
Subject Category
Aerospace Medicine
Accession Number
87A50317
Funding Number(s)
CONTRACT_GRANT: NAS9-15147
Distribution Limits
Public
Copyright
Other

Available Downloads

There are no available downloads for this record.
No Preview Available